Alignment Healthcare Q3 revenue beats; FY adjusted core profit outlook lowered

By Reuters News


Overview

  • US Medicare Advantage insurer's Q3 revenue grew 36.7% yr/yr, beating analyst expectations

  • Q3 adjusted EBITDA declined 32.8% yr/yr and missed analyst estimates

  • Company lowered full-year adjusted gross profit and adjusted EBITDA guidance due to higher medical costs


Outlook

  • Company expects Q4 revenue of $1.316 bln

  • Alignment Healthcare forecasts 2026 full-year revenue of $5.245 bln

  • Company lowers 2026 full-year adjusted gross profit and adjusted EBITDA guidance


Result Drivers

  • MEMBERSHIP GROWTH - Co said Q3 revenue growth was driven by a 31.2% yr/yr increase in health plan membership

  • HIGHER MEDICAL COSTS - Co attributed lower adjusted gross profit and EBITDA to increased medical costs, including elevated appeals, disputes, catastrophic cases and skilled nursing


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$1.36 bln

$1.31 bln (11 Analysts)

Q3 Net Loss

$8.1 mln

Q3 Adjusted EBITDA

Miss

$21.8 mln

$22.80 mln (13 Analysts)


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the managed healthcare peer group is "buy"

  • Wall Street's median 12-month price target for Alignment Healthcare, Inc. is $11.50, about 40.6% above its October 28 closing price of $8.18

  • The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 77 three months ago


Reuters Recommended Reads

  • Oct 27 - Centene Q3 revenue tops estimates on Medicare growth

  • Oct 27 - HCA signals flat 2027 earnings as Medicaid payments drop; shares slide

  • Oct 27 - Universal Health warns of possible impact to annual results from Medicaid changes; Q3 revenue slightly beats


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk